Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is a leading provider of integrated software, payments, and engagement platform for healthcare organizations. The company's platform is designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Despite a sequential decline in subscription revenue due to deliberate pricing actions, management is prioritizing retention, client ROI, and platform monetization which will likely result in sustainable growth and a structural advantage over competitors. The company's strong reputation in the market, along with its ability to monetize customers across multiple revenue streams, positions them well for success in the constantly evolving healthcare industry. In addition, the recent acquisition of AccessOne and a partnership with OpenEvidence are expected to contribute to future growth. While there are some headwinds in the industry, such as the pharma patent cliff and competition for healthcare ad budgets, Phreesia is well-positioned to navigate these challenges and continue its upward trajectory.

Bears say

Phreesia is facing several challenges that could negatively impact its stock. The company relies heavily on its Phreesia Platform to generate revenue, but it faces tough competition from other healthcare software companies. Its revenue growth has slowed down in recent quarters, and it may struggle to maintain its current valuation in a market where investors are increasingly cautious about the healthcare sector. In addition, Phreesia's expected revenue from its CueSquared business has not matched expectations, and its missing revenue from Network Solutions is eating into its margin opportunities.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.